Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...
R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...
The US Food and Drug Administration (FDA) has granted Concept Medical an investigational device exemption (IDE) for its MagicTouch arteriovenous fistula (AVF) catheter, allowing the company to ...
Ide-cel is intended to treat patients with heavily pre-treated relapsed and refractory multiple myeloma, AND was submitted to the FDA in March.
The FDA has given a 27 March 2021 review date for Bristol-Myers Squibb’s multiple myeloma cell therapy ide-cel, just in time to meet a contingent value right (CVR) due to Celgene shareholders if ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in ...